Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIPK3 maintains sensitivity to platinum drugs and prevents disease progression in gastric cancer

21 Jan 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to RNA modifications and cancer
Share to Cancer Genomics and Diagnostics
Share to Cancer-related Molecular Pathways

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38246220
DOI: 10.1016/j.canlet.2024.216643

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIPK3 maintains sensitivity to platinum drugs and prevents disease progression in gastric cancerPMID 38246220Read ↗

Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cellsSemantic proximity Read ↗

MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cellsSemantic proximity Read ↗

TRIM21 improves apatinib treatment in gastric cancer through suppressing EZH1 stabilitySemantic proximity Read ↗

CircSCUBE3 Reduces the Anti-gastric Cancer Activity of Anti-PD-L1Semantic proximity Read ↗

PI3 expression predicts recurrence after chemotherapy with DNA ‐damaging drugs in gastric cancerSemantic proximity Read ↗

The Sweet Side of HIPK2Semantic proximity Read ↗

Tumor Suppressor HIPK2 Regulates Malignant Growth via Phosphorylation of Notch1.Semantic proximity Read ↗

ATR-CHK1 Axis Inhibitors in Gastric Cancer TreatmentSemantic proximity Read ↗

Posttranslational modifications regulate HIPK2, a driver of proliferative diseasesSemantic proximity Read ↗

Epigenetic alterations of TP53INP1 by EHMT2 regulate the cell cycle in gastric cancerSemantic proximity Read ↗

Ablation of glypican-3 enhances radiosensitivity in liver cancer by prolonging G2/M arrest and activating the ATM/CHK2 pathwaySemantic proximity Read ↗

CHK1 expression in Gastric Cancer is modulated by p53 and RB1/E2F1: implications in chemo/radiotherapy responseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.